SUBSCRIBE NOW

SIGHT

Be informed. Be challenged. Be inspired.

“Don’t panic”: WHO says after widespread suspension of AstraZenaca vaccine

Reuters

The World Health Organisation on Monday urged countries not to panic as several nations halted the use of the AstraZeneca COVID-19 vaccine.

The WHO appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide. WHO Director-General Tedros said systems were in place to protect public health.

Coronavirus AstraZeneca vaccine

Vials labelled “AstraZeneca COVID-19 Coronavirus Vaccine” and a syringe are seen in front of a displayed AstraZeneca logo in this illustration taken on 10th March. PICTURE: Reuters/Dado Ruvic/Illustration/File photo

Portugal joined Spain, France, Germany, Italy, Denmark, Norway and several other countries in halting the use of the AstraZeneca jab amid concerns over possible serious side-effects.

The WHO said there was no evidence that the incidents are caused by the vaccine developed by AstraZeneca, an Anglo-Swedish company, with Oxford University.

The EU’s EMA medicines regulator said it would meet on Thursday to analyse the situation and reaffirmed its view that the benefits of the drug outweigh the risks. The EMA will assess the information gathered into whether the AstraZeneca shot contributed to thromboembolic events (blood clots) in those inoculated.

The top WHO scientist reiterated on Monday that there have been no documented deaths linked to COVID-19 vaccines.

“We do not want people to panic,” Soumya Swaminathan said on a virtual media briefing, adding there has been no association, so far, pinpointed between so-called “thromboembolic events” reported in some countries and COVID-19 shots.

WHO chief Tedros Adhanom Ghebreyesus said an advisory committee meeting on AstraZeneca would be held on Tuesday. EU medicines regulator EMA will also convene this week to assess the information gathered into whether the AstraZeneca shot contributed to thromboembolic events in those inoculated.

The moves by some of Europe’s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca’s.

 

Donate



sight plus logo

Sight+ is a new benefits program we’ve launched to reward people who have supported us with annual donations of $26 or more. To find out more about Sight+ and how you can support the work of Sight, head to our Sight+ page.

Musings

TAKE PART IN THE SIGHT READER SURVEY!

We’re interested to find out more about you, our readers, as we improve and expand our coverage and so we’re asking all of our readers to take this survey (it’ll only take a couple of minutes).

To take part in the survey, simply follow this link…

Leave a Reply

Your email address will not be published. Required fields are marked *

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.